References
- Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001; 84:48–51
- Cox A, Jenkins V, Catt S, . Information needs and experiences: an audit of UK cancer patients. Eur J Oncol Nurs 2006; 10:263–72
- McGurk R, Fallowfield L, Winters Z. Information provision for patients by breast cancer teams about the side-effects of hormone treatments. Eur J Cancer 2006; 42:1760–7
- Chamberlain WM, Tulman L, Coleman EA, . Women's perceptions of the effectiveness of telephone support and education on their adjustment to breast cancer. Oncol Nurs Forum 2006; 33:138–44
- Fallowfield L, Jenkins V. Communicating sad, bad, and difficult news in medicine. Lancet 2004; 363:312–9
- Kraetschmer N, Sharpe N, Urowitz S, . How does trust affect patient preferences for participation in decision-making? Health Expect 2004; 7:317–26
- Mallinger JB, Griggs JJ, Shields CG. Patient-centered care and breast cancer survivors’ satisfaction with information. Patient Educ Couns 2005; 57:342–9
- Avis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol 2005; 23:3322–30
- Manuel JC, Burwell SR, Crawford SL, . Younger women's perceptions of coping with breast cancer. Cancer Nurs 2007; 30:85–94
- Fallowfield LJ, Jenkins VA, Beveridge HA. Truth may hurt but deceit hurts more: communication in palliative care. Palliat Med 2002; 16:297–303
- Han WT, Collie K, Koopman C, . Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology 2005; 14:318–30
- Shanafelt TD. Finding meaning, balance, and personal satisfaction in the practice of oncology. J Support Oncol 2005; 3:157–62, 164
- ATAC Trialists’ Group. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005; 365:60–2
- Coates AS, Keshaviah A, Thurlimann B, . Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1–98. J Clin Oncol 2007; 25:486–92
- Coombes RC, Kilburn LS, Snowdon CF, . Survival and safety of exemestane versus tamoxifen after 2–3 years’ tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 2007; 369:559–70
- The ATAC Trialists’ Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol 2006; 7:633–43
- Fallowfield L, Jenkins V, Farewell V, . Efficacy of a cancer research UK communication skills training model for oncologists: a randomised controlled trial. Lancet 2002; 359:650–6
- Jenkins V, Fallowfield L. Can communication skills training alter physicians’ beliefs and behavior in clinics? J Clin Oncol 2002; 20:765–9
- Fallowfield L, Jenkins V, Farewell V, . Enduring impact of communication skills training: results of a 12-month follow up. Br J Cancer 2003; 89:1445–9
- Wengstrom Y, Aapro M, Leto DP, . Patients’ knowledge and experience of adjuvant endocrine therapy for early breast cancer: a European study. Breast 2007; 16:462–8
- Jenkins VA, Fallowfield LJ, Poole K. Are members of multidisciplinary teams in breast cancer aware of each other's informational roles? Qual Health Care 2001; 10:70–5
- Rawl SM, Given BA, Given CW, . Intervention to improve psychological functioning for newly diagnosed patients with cancer. Oncol Nurs Forum 2002; 29:967–75